| systematic review | Q1504425 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1041503077 |
| P356 | DOI | 10.1007/S12325-015-0228-Y |
| P8608 | Fatcat ID | release_vih6yytgxvg25jbv7zo2ngddb4 |
| P932 | PMC publication ID | 4522025 |
| P698 | PubMed publication ID | 26202828 |
| P5875 | ResearchGate publication ID | 280390889 |
| P50 | author | Anastasios G P Konstas | Q89460814 |
| Dimitrios G Mikropoulos | Q125206031 | ||
| Catey Bunce | Q28039205 | ||
| Kostas G Boboridis | Q52349976 | ||
| P2093 | author name string | Jimmy Uddin | |
| Irini C Voudouragkaki | |||
| George Mangouritsas | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| Surgical orbital decompression for thyroid eye disease | Q24234593 | ||
| Three-wall orbital decompression superiority to 2-wall orbital decompression in thyroid-associated ophthalmopathy | Q83187627 | ||
| Medial wall decompression for optic neuropathy but lateral wall decompression with fat removal for non vision-threatening indications | Q83296025 | ||
| Ultrasonic bone removal versus high-speed burring for lateral orbital decompression: comparison of surgical outcomes for the treatment of thyroid eye disease | Q83377615 | ||
| The application of stereotactic navigation surgery to orbital decompression for thyroid-associated orbitopathy | Q84005949 | ||
| Stereotaxy for surgical navigation in orbital surgery | Q84254924 | ||
| Large meningoencephalocele after orbital decompression | Q84532854 | ||
| A step towards individualized, anatomy-based surgical concepts for orbital decompression in Graves' orbitopathy | Q84746788 | ||
| Rehabilitative orbital decompression for Graves' orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients' satisfaction | Q85203231 | ||
| Acute thyroid eye disease (TED): principles of medical and surgical management | Q26827429 | ||
| The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860537 | ||
| How to identify randomized controlled trials in MEDLINE: ten years on | Q29620317 | ||
| Maximal, three-wall, orbital decompression through a coronal approach | Q30428680 | ||
| Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial | Q30481543 | ||
| Treatment of proptosis with fat removal orbital decompression in Graves' ophthalmopathy. | Q31932420 | ||
| Results of diplopia and strabismus in patients with severe thyroid ophthalmopathy after orbital decompression | Q33771426 | ||
| Management of Graves' ophthalmopathy: reality and perspectives | Q33899550 | ||
| Epidemiology and prevention of Graves' ophthalmopathy | Q34165523 | ||
| Immunosuppressive therapy in patients with thyroid eye disease: an overview of current concepts | Q34199530 | ||
| Horizontal eye position in thyroid eye disease: a retrospective comparison with normal individuals and changes after orbital decompression surgery | Q34627770 | ||
| The importance of rim removal in deep lateral orbital wall decompression | Q35095714 | ||
| Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. | Q35305938 | ||
| Reversal of dysthyroid optic neuropathy following orbital fat decompression | Q35315008 | ||
| Orbital decompression: a comparison between trans-fornix/transcaruncular inferomedial and coronal inferomedial plus lateral approaches | Q35587821 | ||
| Endoscopical Orbital Fat Decompression with Medial Orbital Wall Decompression for Dysthyroid Optic Neuropathy | Q35592934 | ||
| Effects of Graves' ophthalmopathy on quality of life | Q35785147 | ||
| Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt | Q36069781 | ||
| Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards | Q36728722 | ||
| Transpalpebral decompression of endocrine ophthalmopathy by intraorbital fat removal (Olivari technique): experience and progression after more than 3000 operations over 20 years | Q36850715 | ||
| The transconjunctival approach with lateral canthal extension for three-wall orbital decompression in thyroid orbitopathy | Q37341202 | ||
| Surgical treatment of dysthyroid orbitopathy | Q37533258 | ||
| Orbital decompression in thyroid eye disease | Q37556318 | ||
| Graves' orbitopathy: imperfect treatments for a rare disease | Q37582446 | ||
| Small versus coronal incision orbital decompression in Graves' orbitopathy | Q37617387 | ||
| Orbital fat decompression for Graves' orbitopathy: a literature review | Q37751779 | ||
| Comparison of lateral and medial orbital decompression for the treatment of compressive optic neuropathy in thyroid eye disease | Q37782247 | ||
| The management of patients with thyroid eye disease after bilateral orbital 3 wall decompression | Q37884063 | ||
| Treatment options for Graves' orbitopathy | Q37992118 | ||
| Surgical treatment of Graves' ophthalmopathy | Q38013217 | ||
| Diplopia secondary to orbital surgery | Q38045886 | ||
| Effect of orbital decompression on diplopia in thyroid-related orbitopathy | Q38183690 | ||
| Optic neuropathy in thyroid eye disease: results of the balanced decompression technique | Q38207225 | ||
| Stereotactic microdebrider in deep lateral orbital decompression for patients with thyroid eye disease | Q38207888 | ||
| Orbital fat decompression for thyroid eye disease: retrospective case review and criteria for optimal case selection | Q38246849 | ||
| Surgical effects of various orbital decompression methods in thyroid-associated orbitopathy: computed tomography-based comparative analysis. | Q39199251 | ||
| Advances in surgical rehabilitation in thyroid eye disease | Q40054472 | ||
| Thyroid-associated ophthalmopathy: pathogenesis and clinical management. | Q40511567 | ||
| Orbital decompression for the management of thyroid eye disease: An analysis of outcomes and complications | Q41042475 | ||
| Transcaruncular approach to the medial orbit and orbital apex | Q41751757 | ||
| Strabismus after balanced medial plus lateral wall versus lateral wall only orbital decompression for dysthyroid orbitopathy | Q41752178 | ||
| Strabismus after inferior-medial wall orbital decompression in thyroid-related orbitopathy. | Q43663148 | ||
| Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study | Q43705603 | ||
| Long-term follow-up of patients with thyroid eye disease treated with endoscopic orbital decompression | Q43882744 | ||
| Treatment of severe thyroid eye disease: a survey of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS). | Q45852178 | ||
| Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures | Q46083146 | ||
| Primary-gaze diplopia in patients with thyroid-related orbitopathy undergoing deep lateral orbital decompression with intraconal fat debulking: a retrospective analysis of treatment outcome | Q46174774 | ||
| Surgical correction of exophthalmos secondary to Graves' disease | Q46247151 | ||
| Strabismus after deep lateral wall orbital decompression in thyroid-related orbitopathy patients using automated hess screen | Q46569660 | ||
| Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial | Q46665485 | ||
| Incidence of hyperthyroidism in Sweden | Q46963719 | ||
| Transcaruncular orbital decompression: an alternate procedure for Graves ophthalmopathy with compressive optic neuropathy | Q46982986 | ||
| Stereotactic Navigation With a Registration Mask in Orbital Decompression Surgery: Preliminary Results. | Q50601459 | ||
| Rationale of treatment in Graves ophthalmopathy. | Q50759995 | ||
| Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. | Q50933902 | ||
| Orbital decompression for thyroid-associated orbitopathy in England: trends over time and geographical variation. | Q51232684 | ||
| Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center. | Q51258119 | ||
| Incidence and treatment of diplopia after three-wall orbital decompression in Graves' ophthalmopathy. | Q51632842 | ||
| Orbital fat removal. Decompression for Graves orbitopathy. | Q51664950 | ||
| Results and predictability of fat-removal orbital decompression for disfiguring graves exophthalmos in an Asian patient population. | Q51716973 | ||
| Transcaruncular orbital decompression for management of compressive optic neuropathy in thyroid-related orbitopathy. | Q52551751 | ||
| Compression and stretching in Graves orbitopathy: emergency orbital decompression techniques. | Q53143687 | ||
| Orbital lipectomy (fat decompression) for thyroid eye disease: an operation for everyone? | Q53243373 | ||
| Transconjunctival fat removal combined with conservative medial wall/floor orbital decompression for Graves orbitopathy. | Q53353546 | ||
| A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. | Q53359335 | ||
| Piezosurgery for orbital decompression surgery in thyroid associated orbitopathy. | Q53492470 | ||
| Endoscopic orbital decompression for thyroid eye disease. | Q53551502 | ||
| Surgical Treatment of Dysthyroid Optic Neuropathy: Long-Term Visual Outcomes with Comparison of 2-Wall versus 3-Wall Orbital Decompression. | Q53557886 | ||
| The removal of the deep lateral wall in orbital decompression: its contribution to exophthalmos reduction and influence on consecutive diplopia. | Q53571441 | ||
| Balanced orbital decompression combined with fat removal in Graves ophthalmopathy: do we really need to remove the third wall? | Q53656516 | ||
| Ethmoidectomy decompression for the treatment of Graves' optic neuropathy | Q53731026 | ||
| Transnasal endoscopic orbital decompression and Graves' ophtalmopathy. | Q54044818 | ||
| Transcaruncular medial wall orbital decompression: an effective approach for patients with unilateral graves ophthalmopathy | Q58914743 | ||
| Modification of the Classification of the Eye Changes of Graves' Disease: Recommendations of the Ad Hoc Committee of The American Thyroid Association | Q67020629 | ||
| The pathogenesis of Graves' ophthalmopathy | Q68947222 | ||
| Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy | Q69288448 | ||
| An individualized approach to orbital decompression in Graves' orbitopathy | Q69802470 | ||
| Transpalpebral decompression of endocrine ophthalmopathy (Graves' disease) by removal of intraorbital fat: experience with 147 operations over 5 years | Q70125543 | ||
| Treatment of exophthalmos by orbital fat removal | Q70692757 | ||
| Thyroid-associated orbitopathy: transpalpebral decompression by removal of intraorbital fat. Experience with 1362 orbits in 697 patients over 13 years | Q73310783 | ||
| [Orbit decompression surgery in patients with exophthalmos caused by Graves-Basedow disease] | Q73558805 | ||
| Combined endoscopic and subciliary orbital decompression for thyroid-related compressive optic neuropathy | Q73952377 | ||
| The evolving paradigm of orbital decompression surgery | Q74100108 | ||
| Surgical treatment of endocrine exophthalmos by removal of orbital fat: clinical experience | Q78526475 | ||
| Transforniceal lateral deep bone decompression--a modified technique to prevent postoperative diplopia in patients with disfiguring exophthalmos due to dysthyroid orbitopathy | Q80174066 | ||
| Is orbital decompression a safe and effective treatment for Graves' orbitopathy? | Q80854529 | ||
| Outcome of deep lateral wall rim-sparing orbital decompression in thyroid-associated orbitopathy: a new technique and results of a case series | Q82760866 | ||
| P4510 | describes a project that uses | systematic review | Q1504425 |
| literature search | Q12324699 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human musculoskeletal system | Q726543 |
| eye disease | Q3041498 | ||
| orbit | Q156075 | ||
| P304 | page(s) | 595-611 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Advances in Therapy | Q4686392 |
| P1476 | title | Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search | |
| P478 | volume | 32 |
| Q38769722 | Advances in the pharmacological treatment of Graves' orbitopathy |
| Q47814599 | Complications and outcomes of grafting of posterior orbital fat into the lower lid-cheek junction during orbital decompression |
| Q55001461 | Cutting-edge endonasal surgical approaches to thyroid ophthalmopathy. |
| Q61797316 | Development of a core outcome set for amblyopia, strabismus and ocular motility disorders: a review to identify outcome measures |
| Q40095263 | Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management |
| Q87885684 | Extraocular muscle repositioning as the last therapeutic option for a patient with a severe course of Graves' Ophthalmopathy: a case report |
| Q41505945 | Fat-removal orbital decompression for thyroid associated orbitopathy: The right procedure for the right patient |
| Q39159003 | Orbital Decompression for Thyroid Eye Disease |
| Q58767198 | Orbital decompression surgery for the treatment of Graves' ophthalmopathy: comparison of different techniques and long-term results |
| Q38680245 | Piezosurgery in modified pterional orbital decompression surgery in Graves' disease |
| Q49946639 | Rehabilitative orbital decompression for Graves' orbitopathy: results of a randomized clinical trial. |
| Q45157144 | Surgical Freedom Evaluation During Optic Nerve Decompression: Laboratory Investigation |
| Q36811289 | The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy |
| Q93333216 | Tocilizumab for thyroid eye disease |
| Q94355143 | Tocilizumab for thyroid eye disease |
| Q54325672 | [Orbital decompression : Indications, technique, results]. |
Search more.